Activated immune system in patients with Huntington's disease

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 10, 1998, Pages 747-750

  Leblhuber, Friedrich ^a   Walli, Johannes ^a   Jellinger, Kurt ^b   Tilz, Gernot P ^c   Widner, Bernhard ^d   Laccone, Franco ^e   Fuchs, Dietmar ^d  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Huntington's disease; Immune activation; Neopterin; Serum soluble receptors; Tryptophan

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; KYNURENINE; NEOPTERIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; CELLULAR IMMUNITY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; HUNTINGTON CHOREA; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL;

EID: 0031743376     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.132     Document Type: Article

References (18)

1. Martin JB. Huntington's disease: new approaches to an old problem. Neurology 1984; 34:1059-72.
2. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:971-83.
3. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 1994; 344:796-8.
4. Barkley DS, Hardiwidjaja SI, Tourtellotte WW, Menkes JH. Cellular immune responses in Huntington's disease. Neurology 1978; 28:32-5.
5. Blass JB. Pathophysiology of the Alzheimer's syndrome. Neurology 1993;43 (Suppl 4):S25-38.
6. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 1993; 101:1-6.
7. Heyes MP, Saito K, Crowley JS, Davies LE, Demitrack MA, Der M, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115:1249-73.
8. Gasse T, Murr C, Meyersbach P, Schmutzhard E, Wachter H, Fuchs D. Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy. Eur J Clin Chem Clin Biochem 1994; 32:685-9.
9. Leblhuber F, Walli J, Tilz GP, Wachter H, Fuchs D. Systemische Immunsystemveränderungen bei Patienten mit Alzheimer'scher Demenz. Deutsche Med Wochenschr 1998; 123:787-91.
10. Shoulson I, Fahn S. Huntington's disease: clinical care and evaluation. Neurology 1979; 29:1-3.
11. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43:2424-7.
12. Hagberg L, Dotevall L, Norkrans G, Larrson M, Wachter H, Fuchs D. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 1993; 168:1285-8.
13. Schwarcz R, Tamminga CA, Kurlan R, Shoulson I. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and Schizophrenia. Ann Neurol 1988; 24:580-2.
14. Beal MF. Does impairmant of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992; 31:119-30.
15. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54:1-8.
16. Leblhuber F, Walli J, Tilz GP, Jellinger K, Wachter H, Fuchs D. Increased serum neopterin concentrations in a patient with Creutzfeld-Jakob disease. J Neurol Neurosurg Psych 1996; 10:138-9.
17. Fuchs D, Möller AA, Reibnegger G, Stöckl E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3:873-6.
18. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Lett 1989; 23:103-8.